tirzepatide single dose pen vs Semaglutide: Key Differences Explained Eli Lilly launches Zepbound obesity

Discov Med 2 , 302 (2025)

Disordered eating

GLP-1 medications are known for their appetite-suppressing effects, which can alter familiar hunger cues

somewhat more potent at inhibiting DAT than racemic modafinil, with equally negligible action on NET and SERT) RTI-229 Vanoxerine (GBR-12909) DRIs with substantial activity at other sites [edit] Amantadine (also a weak NMDA receptor antagonist) Benztropine (also a muscarinic antagonist) Bupropion (also a more potent NRI and likely NRA due to bupropion's major metabolite hydroxybupropion) Cocaine Fluorenol (extremely weak) Medifoxamine (relatively weak) Metaphit (irreversible

In ARVC clinical cohorts, mutations in the Plakophilin 2 (PKP2) gene are most commonly detected, 293,294 making it a focal point for translational research

Is DAO deficiency the same as HNMT deficiency